Medical Cannabis on NHS: Scotland Pilot Programme Publishes Results
Scotland's NHS medical cannabis pilot programme has published interim results showing significant patient benefit across chronic pain and PTSD cohorts, with implications for future NHS prescribing policy.
The NHS Scotland medical cannabis pilot programme has published its interim results, providing the most substantial real-world NHS evidence for cannabis-based medicines in the UK to date. The results demonstrate meaningful clinical benefit across the two primary treatment cohorts, chronic pain and post-traumatic stress disorder, and are expected to inform future policy discussions about NHS prescribing.
Pilot Programme Overview
The pilot enrolled 312 patients across multiple NHS health boards in Scotland, with participants randomised to receive either cannabis-based medicines or continued standard care. The programme was designed to generate the kind of real-world NHS evidence that NICE and policymakers require to make decisions about expanding prescribing pathways.
- 312 patients enrolled across four NHS health boards
- Two primary cohorts: chronic pain with 186 participants and PTSD with 126 participants
- Average follow-up period of 18 months
- Outcome measures included pain scores, quality of life, and medication usage
Key Results
In the chronic pain cohort, 73% of participants reported clinically meaningful reductions in pain scores by month six. In the PTSD cohort, 68% reported significant improvement in core symptom clusters. In both groups, a substantial proportion of participants were able to reduce dosages of other medications, including opioids and benzodiazepines.
Policy Implications
The pilot results will be submitted to NICE as part of the evidence review process for updated medical cannabis guidance. Scottish Government health officials have indicated that the findings will also inform decisions about potential expansion of NHS prescribing beyond the current narrow set of approved indications.
For patients in Scotland and across the UK, our chronic pain and PTSD guides provide condition-specific information. Our clinic directory covers both private and NHS-linked providers. Our prescription guide explains how to access treatment today.
